An international study concludes the hormone drug tamoxifen continues to reduce a woman's risk of breast cancer recurrence for several years after she stops taking the drug. The course of taking tamoxifen to block the effect of the estrogen hormone normally is five years, but the study said the risk reduction lasted at least as long as eight years.

Full Story:

Related Summaries